Fig. 1From: Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysisPRISMA flow diagrams for A Crohn’s disease and B ulcerative colitis. Abbreviation: PRISMA Preferred reporting items for systematic reviews and meta-analysesBack to article page